These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4914940)

  • 1. Recommended criteria for the identification of trachoma and inclusion conjunctivitis agents.
    Schachter J
    J Infect Dis; 1970; 122(1):105-7. PubMed ID: 4914940
    [No Abstract]   [Full Text] [Related]  

  • 2. Conjunctival swabbing for the isolation of TRIC agent (Chlamydia).
    Darougar S; Jones BR
    Br J Ophthalmol; 1971 Sep; 55(9):585-90. PubMed ID: 4938312
    [No Abstract]   [Full Text] [Related]  

  • 3. EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT.
    Mitsui Y; Konishi K; Nishimura A; Kajima M; Tamura O; Endo K
    Br J Ophthalmol; 1962 Nov; 46(11):651-9. PubMed ID: 18170828
    [No Abstract]   [Full Text] [Related]  

  • 4. Folliculosis, TRIC (trachoma--inclusion conjunctivitis) and the carrier state.
    Scott JG; Cuthbertson EM; Ryan J
    S Afr J Med Sci; 1972 Jul; 37(1):23-5. PubMed ID: 4656286
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia.
    Darougar S; Treharne JD; Dwyer RS; Kinnison JR; Jones BR
    Br J Ophthalmol; 1971 Sep; 55(9):591-9. PubMed ID: 4106450
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and identification of trachoma and inclusion conjunctivitis agents in Melbourne, 1966 to 1972.
    Graham DM; Pinkard KJ; Layton JE; Greer CH; Davis JA
    Med J Aust; 1973 Jun; 1(22):1095-9. PubMed ID: 4351871
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the microbiology of trachoma and related diseases.
    Jones BR
    Trans Ophthalmol Soc N Z; 1973; 25():187-91. PubMed ID: 4586696
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative sensitivity of cell culture and yolk sac for detection of TRIC infection.
    Gordon FB; Dressler HR; Quan AL
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1044-8. PubMed ID: 6067304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isolation and serial culture of strains of the agents of inclusion conjunctivitis and inclusion blennorrhea].
    Nabli B
    Bull World Health Organ; 1969; 40(3):365-73. PubMed ID: 4896167
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory tests for chlamydial infection. Their role in epidemiological studies of trachoma and its control.
    Jones BR
    Br J Ophthalmol; 1974 Apr; 58(4):438-54. PubMed ID: 4606714
    [No Abstract]   [Full Text] [Related]  

  • 11. A study of urethritis in males with particular reference to mycoplasma and TRIC-agent.
    Mukhija RD; Gupta U; Bhujwala RA; Mahajan VM; Bhutani LK; Kandhari KC
    Indian J Med Res; 1973 Dec; 61(12):1766-70. PubMed ID: 4206938
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative isolations of TRIC agent in the yolk sacs and the amniotic cavities of chick embryos.
    Harisijades SS; Harisijades BS
    Acta Med Iugosl; 1967; 21(2):223-30. PubMed ID: 4883476
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of human genital TRIC agents in nongonococcal urethritis and Reiter's disease by an irradiated cell culture method.
    Ford DK; McCandlish L
    Br J Vener Dis; 1971 Jun; 47(3):196-7. PubMed ID: 5104542
    [No Abstract]   [Full Text] [Related]  

  • 14. The agent of trachoma. Recent studies of the biology, biochemistry and immunology of a prokaryotic obligate parasite of eukaryocytes.
    Becker Y
    Monogr Virol; 1974; 7():1-99. PubMed ID: 4364815
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G.
    Treharne JD; Darougar S; Jones BR
    Br J Vener Dis; 1973 Jun; 49(3):295-300. PubMed ID: 4578214
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics and unknowns of TRIC agents (trachoma--inclusion conjunctivitis)].
    Nabli B
    Rev Int Trach Pathol Ocul Trop Subtrop; 1980; 57(4):71-5. PubMed ID: 7280402
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on oculogenital TRIC agents isolated in Denmark.
    Mordhorst CH
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1282-8. PubMed ID: 6025166
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. II. Experiments with a 'slow-killing' strain.
    Collier LH; Mogg AE
    J Hyg (Lond); 1969 Sep; 67(3):449-55. PubMed ID: 4980360
    [No Abstract]   [Full Text] [Related]  

  • 19. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys.
    Wang SP; Grayston JT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1133-45. PubMed ID: 4960878
    [No Abstract]   [Full Text] [Related]  

  • 20. Virulence of trachoma-inclusion conjunctivitis agent after passage in baboons.
    Moore JE; Griffiths MS; Pearce JH
    Br J Exp Pathol; 1970 Jun; 51(3):298-304. PubMed ID: 4987927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.